We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
With little choice during the pandemic, many patients adjusted to virtual visits. Now they’re likely here to stay due to conv…
U.S. medical experts authorize an additional booster for some people with immune system problems to keep their defenses up ag…
Research found slightly more than half of HAE patients who had COVID-19 experienced a swelling attack while infected.
Lean into the momentum and innovation that the global pandemic inspired, CSL CEO Paul Perreault told attendees of The Economi…
Perreault returned to Australia as soon as its doors reopened to visitors. He kept a busy schedule, speaking at the Melbourne…
Australian government donates millions of Oxford-AstraZeneca COVID-19 vaccines manufactured by CSL to neighboring nations, in…
The virus that causes COVID-19 mainly spreads in the air, so antibacterial wipes and other deep-cleaning methods for surfaces…
Colds are circulating and it’s flu season. Time to test your knowledge about keeping hands clean.
A glossy magazine feature spotlights four women who played key roles in Australia’s COVID-19 vaccine development, including C…
Leaders in science convened to discuss the most pressing topics in biotech, medicine and policy at the 2021 STAT Summit.
In an update, immunologist says most PID patients appear no more at risk than the general population.
Should you get both vaccinations? Yes, says an infectious disease doctor with the U.S. National Foundation for Infectious Dis…
Popular search terms:
Americas
Asia Pacific
Middle East
Europe
